ICD-10 Coding for Hypergammaglobulinemia(D47.2, D47.2M, D89.0)
Comprehensive guide to ICD-10 coding for hypergammaglobulinemia, including documentation requirements and coding pitfalls.
Complete code families applicable to Hypergammaglobulinemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D89.0 | Polyclonal hypergammaglobulinemia | Use when polyclonal hypergammaglobulinemia is confirmed by laboratory tests. |
|
| D89.2 | Hypergammaglobulinemia, unspecified | Use when hypergammaglobulinemia is present but not further specified. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHypergammaglobulinemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hypergammaglobulinemia.
Lack of specific pattern documentation
Impact
Clinical: Misdiagnosis risk, Regulatory: Non-compliance with coding standards, Financial: Potential reimbursement issues
Mitigation
Ensure lab results are reviewed, Clarify documentation with providers
Using D89.0 for monoclonal gammopathy
Impact
Reimbursement: Incorrect DRG assignment may occur., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Verify SPEP results to confirm polyclonal pattern before coding.
Pattern Documentation
Impact
Failure to document specific pattern can lead to audit discrepancies.
Mitigation
Implement mandatory SPEP result inclusion in records.